Also trades as: RCE.AX (ASX) · $vol 0M
RECEF OTC
Recce Pharmaceuticals Ltd
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: -63.3%
$0.22
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$10M
+49.9% ▲
Capital Expenditures
$64K
-143.7% ▼
5Y CAGR: -3.3%
Free Cash Flow
-$10M
+49.6% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$8M
-224.3% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$11M | -$13M | -$18M | $0 | -$16M |
| Depreciation & Amort. | $188K | $217K | $367K | $0 | $369K |
| Stock-Based Comp. | $256K | $325K | $20K | $0 | $0 |
| Change in Working Capital | $2M | -$152K | $4M | -$182K | $3M |
| Other Non-Cash Items | $456K | -$98K | $0 | -$20M | $2M |
| Operating Cash Flow | -$9M | -$13M | -$13M | -$20M | -$10M |
| — Investing Activities — | |||||
| Capital Expenditures | -$40K | -$39K | -$142K | -$26K | -$64K |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | -$237K | -$1K |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $0 | $0 | -$181K | $193K |
| Investing Cash Flow | -$40K | -$39K | -$142K | -$444K | $128K |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $3M | $6M | $591K | -$1M |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$528K | -$275K | -$1M | -$2M | -$298K |
| Financing Cash Flow | -$240K | $3M | $16M | $27M | $2M |
| Net Change in Cash | -$9M | -$10M | $3M | $6M | -$8M |
| Cash End of Period | $12M | $2M | $4M | $10M | $3M |
| Free Cash Flow | -$9M | -$13M | -$13M | -$20M | -$10M |